New C****-** V*****e Boosters Perform Poorly Against Symptomatic Infection: CDC Study
Nov 24, 2022 08:40:23 #
Yes, according to a U.S. Centers for Disease Control and Prevention (CDC) study published on Nov. 22.
The protection was 43 percent, 25 percent, and 19 percent following receipt of a bivalent after three shots.
Effectiveness of Bivalent m**A V*****es in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
https://www.cdc.gov/mmwr/volumes/71/wr/mm7148e1.htm?s_cid=mm7148e1_w
https://www.cdc.gov/mmwr/pdf/other/su6004.pdf
C****-** Booster Protection Against Hospitalization Drops Sharply Within Months
https://www.theepochtimes.com/new-c****-**-v*****e-boosters-perform-poorly-against-symptomatic-infection-cdc-study_4879371.html?utm_source=Health&src_src=Health&utm_campaign=health-2022-11-24&src_cmp=health-2022-11-24&utm_medium=email&est=zkVIdITmoMsqgGx80VO7ueeJRwdVn1QZyDe3836VQNpeBLZKtGagL6SuVAtfxzjE
The protection was 43 percent, 25 percent, and 19 percent following receipt of a bivalent after three shots.
Effectiveness of Bivalent m**A V*****es in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
https://www.cdc.gov/mmwr/volumes/71/wr/mm7148e1.htm?s_cid=mm7148e1_w
https://www.cdc.gov/mmwr/pdf/other/su6004.pdf
C****-** Booster Protection Against Hospitalization Drops Sharply Within Months
https://www.theepochtimes.com/new-c****-**-v*****e-boosters-perform-poorly-against-symptomatic-infection-cdc-study_4879371.html?utm_source=Health&src_src=Health&utm_campaign=health-2022-11-24&src_cmp=health-2022-11-24&utm_medium=email&est=zkVIdITmoMsqgGx80VO7ueeJRwdVn1QZyDe3836VQNpeBLZKtGagL6SuVAtfxzjE
If you want to reply, then register here. Registration is free and your account is created instantly, so you can post right away.